7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Boumans MJ et al. | Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. | 2012 | Ann. Rheum. Dis. | pmid:22072013 |
Wang QP et al. | Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand. | 2012 | Bone | pmid:22634178 |
Terpos E et al. | Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis. | 2011 Nov-Dec | Clin. Exp. Rheumatol. | pmid:22032557 |
Arikan F et al. | C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis: a case-control study. | 2011 Mar-Apr | Int J Oral Maxillofac Implants | pmid:21483881 |
Crespi R et al. | Corticocancellous porcine bone in the healing of human extraction sockets: combining histomorphometry with osteoblast gene expression profiles in vivo. | 2011 Jul-Aug | Int J Oral Maxillofac Implants | pmid:21841997 |
Franke S et al. | Advanced glycation end products affect growth and function of osteoblasts. | 2011 Jul-Aug | Clin. Exp. Rheumatol. | pmid:21906430 |
Rezg R et al. | Inhibitors of vascular calcification as potential therapeutic targets. | 2011 Jul-Aug | J. Nephrol. | pmid:21688249 |
Reyes-GarcÃa R et al. | [Cardiovascular disease and bone metabolism]. | 2011 Aug-Sep | Endocrinol Nutr | pmid:21775224 |
Wang Y et al. | LC, a novel estrone-rhein hybrid compound, concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production by human osteoblastic cells. | 2011 | Mol. Cell. Endocrinol. | pmid:21291955 |
Chang YC and Zhao JH | Effects of platelet-rich fibrin on human periodontal ligament fibroblasts and application for periodontal infrabony defects. | 2011 | Aust Dent J | pmid:22126345 |
Yang L et al. | Osteoprotegerin and osteoprotegerin ligand expression during human marrow stromal cell differentiation and their effect on osteoclast formation. | 2011 | Chin. Med. J. | pmid:22088466 |
Curl L and Sampson W | The presence of TNF-alpha and TNFR1 in aseptic root resorption. A preliminary study. | 2011 | Aust Orthod J | pmid:22372265 |
Kwan JS et al. | Heritability of serum osteoprotegerin. | 2011 | Ann. Hum. Genet. | pmid:21762114 |
Ibrahim T et al. | Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients. | 2011 | Clin. Breast Cancer | pmid:21764390 |
Yamamoto K et al. | Effects of mechanical stress on cytokine production in mandible-derived osteoblasts. | 2011 | Oral Dis | pmid:21771211 |
Chen WJ et al. | Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men. | 2011 | Cardiovasc Diabetol | pmid:21771299 |
Pepene CE et al. | Elevated serum receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in late-onset male hypogonadism. | 2011 | Clin Invest Med | pmid:21810381 |
Sheng L et al. | [Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer--an expatiation viewing from OPG/RANKL/RANK system]. | 2011 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:21812275 |
Yang XY et al. | [Influence of surface modification of titanium on OPG/RANKL mRNA expression in MG-63 human osteoblast-like cells]. | 2011 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:21868322 |
Malliga DE et al. | The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review. | 2011 | Wien Med Wochenschr | pmid:21870142 |
Guo HL et al. | [Experimental study on the mechanism of icariin improving human osteoblasts proliferation and the expression of OPG protein]. | 2011 | Zhongguo Gu Shang | pmid:21870401 |
Loncar G et al. | Association of increased parathyroid hormone with neuroendocrine activation and endothelial dysfunction in elderly men with heart failure. | 2011 | J. Endocrinol. Invest. | pmid:20820131 |
Tripathi A et al. | Bisphosphonate therapy for skeletal malignancies and metastases: impact on jaw bones and prosthodontic concerns. | 2011 | J Prosthodont | pmid:21883630 |
Mohamed GB and Abdel-Latif EA | Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome. | 2011 | Saudi J Kidney Dis Transpl | pmid:21912025 |
Lommi JI et al. | High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification. | 2011 | Atherosclerosis | pmid:21917259 |
Embree M et al. | Role of subchondral bone during early-stage experimental TMJ osteoarthritis. | 2011 | J. Dent. Res. | pmid:21917603 |
Hope S et al. | Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia. | 2011 | J Psychiatr Res | pmid:21889167 |
Shin M et al. | The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. | 2011 | Carcinogenesis | pmid:21890459 |
Giner M et al. | Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis. | 2011 | Eur. J. Pharmacol. | pmid:21050847 |
To M et al. | Osteoprotegerin in sputum is a potential biomarker in COPD. | 2011 | Chest | pmid:21127170 |
Witasp A et al. | Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease. | 2011 | Eur. J. Clin. Invest. | pmid:21128937 |
Khoshniat S et al. | Phosphate-dependent stimulation of MGP and OPN expression in osteoblasts via the ERK1/2 pathway is modulated by calcium. | 2011 | Bone | pmid:21147284 |
Durual S et al. | Titanium nitride oxide coating on rough titanium stimulates the proliferation of human primary osteoblasts. | 2011 | Clin Oral Implants Res | pmid:21087318 |
Ashley DT et al. | Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects. | 2011 | Metab. Clin. Exp. | pmid:21087777 |
Tekkesin MS et al. | The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas. | 2011 | Head Neck Pathol | pmid:21643971 |
Hossein-nezhad A et al. | The influence of folic acid supplementation on maternal and fetal bone turnover. | 2011 | J. Bone Miner. Metab. | pmid:20602129 |
Schoppet M et al. | Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin. | 2011 | Biochem. Biophys. Res. Commun. | pmid:21371424 |
Pobeha P et al. | Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. | 2011 | Bone | pmid:21376149 |
Colombini A et al. | Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing. | 2011 | Int Orthop | pmid:20623281 |
Krause U et al. | Assays of osteogenic differentiation by cultured human mesenchymal stem cells. | 2011 | Methods Mol. Biol. | pmid:21431522 |
Clemens TL and Karsenty G | The osteoblast: an insulin target cell controlling glucose homeostasis. | 2011 | J. Bone Miner. Res. | pmid:21433069 |
Galliera E et al. | Circulating OPG levels are reduced following infliximab treatment and correlate with CRP levels: is serum OPG a potential marker of IBD disease activity? | 2011 | Inflamm. Bowel Dis. | pmid:21433226 |
Hou L et al. | Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts. | 2011 | Acta Vet. Scand. | pmid:21435269 |
Baloul SS et al. | Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. | 2011 | Am J Orthod Dentofacial Orthop | pmid:21435543 |
Wang AY | Consequences of chronic inflammation in peritoneal dialysis. | 2011 | Semin. Nephrol. | pmid:21439430 |
Ikeda K et al. | Conditional expression of constitutively active estrogen receptor α in osteoblasts increases bone mineral density in mice. | 2011 | FEBS Lett. | pmid:21439958 |
Teramachi J et al. | Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis. | 2011 | Lab. Invest. | pmid:21339747 |
Vishvanath A et al. | Infantile haemangioma expresses tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, osteoprotegerin and receptor activator for nuclear factor кB ligand (RANKL). | 2011 | Histopathology | pmid:22034880 |
Vidal C et al. | Functional polymorphisms within the TNFRSF11B (osteoprotegerin) gene increase the risk for low bone mineral density. | 2011 | J. Mol. Endocrinol. | pmid:21994215 |
Hemingway F et al. | In vitro generation of mature human osteoclasts. | 2011 | Calcif. Tissue Int. | pmid:21960377 |
Dimitriadis K et al. | Exercise blood pressure response is related to asymmetric dimethylarginine and osteoprotegerin in hypertension. | 2011 | Int. J. Cardiol. | pmid:21975354 |
Yao Y et al. | Synergistic enhancement of new bone formation by recombinant human bone morphogenetic protein-2 and osteoprotegerin in trans-sutural distraction osteogenesis: a pilot study in dogs. | 2011 | J. Oral Maxillofac. Surg. | pmid:22018252 |
Mödder UI et al. | Regulation of circulating sclerostin levels by sex steroids in women and in men. | 2011 | J. Bone Miner. Res. | pmid:20499362 |
Kaneuji T et al. | Mechanisms involved in regulation of osteoclastic differentiation by mechanical stress-loaded osteoblasts. | 2011 | Biochem. Biophys. Res. Commun. | pmid:21459078 |
Luvizuto ER et al. | Raloxifene therapy inhibits osteoclastogenesis during the alveolar healing process in rats. | 2011 | Arch. Oral Biol. | pmid:21536255 |
Hsieh TP et al. | Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. | 2011 | Phytomedicine | pmid:20554188 |
Al-Dujaili SA et al. | Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro. | 2011 | J. Cell. Biochem. | pmid:21538477 |
Stępień E et al. | Increased levels of bone remodeling biomarkers (osteoprotegerin and osteopontin) in hypertensive individuals. | 2011 | Clin. Biochem. | pmid:21539822 |
Zheng Y et al. | Vitamin D deficiency promotes prostate cancer growth in bone. | 2011 | Prostate | pmid:21541977 |
de Souza JA et al. | Expression of suppressor of cytokine signaling 1 and 3 in ligature-induced periodontitis in rats. | 2011 | Arch. Oral Biol. | pmid:21511249 |
Claro T et al. | Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis. | 2011 | PLoS ONE | pmid:21525984 |
Giro G et al. | Influence of estrogen deficiency on bone around osseointegrated dental implants: an experimental study in the rat jaw model. | 2011 | J. Oral Maxillofac. Surg. | pmid:21530046 |
Won KY et al. | RANK signalling in bone lesions with osteoclast-like giant cells. | 2011 | Pathology | pmid:21532526 |
Xu ML et al. | [An update for the research progress of osteoprotegerin on coronary artery disease]. | 2011 | Zhonghua Xin Xue Guan Bing Za Zhi | pmid:22321243 |
Karosi T et al. | Osteoprotegerin expression and sensitivity in otosclerosis with different histological activity. | 2011 | Eur Arch Otorhinolaryngol | pmid:20963600 |
Halade GV et al. | Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. | 2011 | Exp. Gerontol. | pmid:20923699 |
Mitsuhashi M et al. | Effects of HSP70 on the compression force-induced TNF-α and RANKL expression in human periodontal ligament cells. | 2011 | Inflamm. Res. | pmid:20924639 |
Huang CH et al. | Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis. | 2011 | Rheumatology (Oxford) | pmid:20974615 |
Pepene CE et al. | Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction. | 2011 | Eur. J. Endocrinol. | pmid:20974706 |
Kassi E et al. | Effects of Sideritis euboea (Lamiaceae) aqueous extract on IL-6, OPG and RANKL secretion by osteoblasts. | 2011 | Nat Prod Commun | pmid:22224290 |
Sipos W et al. | OPG-Fc treatment in growing pigs leads to rapid reductions in bone resorption markers, serum calcium, and bone formation markers. | 2011 | Horm. Metab. Res. | pmid:22161252 |
Sobue T et al. | Murine TMJ loading causes increased proliferation and chondrocyte maturation. | 2011 | J. Dent. Res. | pmid:21248355 |
Ribeiro FV et al. | Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis. | 2011 | J. Periodontol. | pmid:21284550 |
Vik A et al. | Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study. | 2011 | J. Thromb. Haemost. | pmid:21284802 |
Akinci B et al. | Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome. | 2011 | Diabetes Res. Clin. Pract. | pmid:20970873 |
Hasegawa T et al. | [Animal models for bone and joint disease. Bone disease of osteoprotegerin deficient mouse]. | 2011 | Clin Calcium | pmid:21289415 |
Toffoli B et al. | Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. | 2011 | Mol. Cell. Endocrinol. | pmid:20832449 |
Qu Z et al. | Effect of enamel matrix derivative on proliferation and differentiation of osteoblast cells grown on the titanium implant surface. | 2011 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:21232997 |
Rauch A et al. | An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. | 2011 | FASEB J. | pmid:21233489 |
Ueland T et al. | Osteoprotegerin predicts progression of chronic heart failure: results from CORONA. | 2011 | Circ Heart Fail | pmid:21216833 |
Tang T et al. | Effect of water-soluble P-chitosan and S-chitosan on human primary osteoblasts and giant cell tumor of bone stromal cells. | 2011 | Biomed Mater | pmid:21205994 |
Jabbar S et al. | Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis. | 2011 | J. Clin. Pathol. | pmid:21307155 |
Maïmoun L et al. | In peripubertal girls, artistic gymnastics improves areal bone mineral density and femoral bone geometry without affecting serum OPG/RANKL levels. | 2011 | Osteoporos Int | pmid:21359671 |
Polzer K et al. | Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis. | 2011 | Arthritis Rheum. | pmid:21360496 |
Oshita K et al. | Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. | 2011 | Arthritis Rheum. | pmid:21360521 |
Wang SY et al. | Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis. | 2011 | J. Rheumatol. | pmid:21362762 |
Preshaw PM and Taylor JJ | How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? | 2011 | J. Clin. Periodontol. | pmid:21323705 |
Sun CX et al. | [Patterns of osteoprotegerin or nuclear factor kappa B ligand gene expression in the treatment of bone defect with bone marrow stem cell transplantation and low-frequency vibration]. | 2011 | Zhonghua Yi Xue Za Zhi | pmid:21600122 |
Basu R et al. | Effects of physiological variations in circulating insulin levels on bone turnover in humans. | 2011 | J. Clin. Endocrinol. Metab. | pmid:21325461 |
Liu ZF et al. | [Effect of ultrasound on osteoprotegerin and receptor activator nuclear factor kappaB ligand expression during root resorption in rats]. | 2011 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:21602131 |
Kamiya N et al. | Significance of serum osteoprotegerin and receptor activator of nuclear factor κB ligand in Japanese prostate cancer patients with bone metastasis. | 2011 | Int. J. Clin. Oncol. | pmid:21327451 |
Eslami B et al. | Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate. | 2011 | Calcif. Tissue Int. | pmid:21327765 |
Blázquez-Medela AM et al. | Osteoprotegerin and diabetes-associated pathologies. | 2011 | Curr. Mol. Med. | pmid:21568931 |
Jørgensen L et al. | Serum osteoprotegerin levels are related to height loss: the Tromsø Study. | 2011 | Eur. J. Epidemiol. | pmid:21331661 |
Feng Z et al. | An oligodeoxynucleotide with promising modulation activity for the proliferation and activation of osteoblast. | 2011 | Int J Mol Sci | pmid:21731457 |
Peng S et al. | Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption. | 2011 | J. Bone Miner. Res. | pmid:21611968 |
Mai QG et al. | Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. | 2011 | J. Cell. Biochem. | pmid:21618594 |
Kornak U | Animal models with pathological mineralization phenotypes. | 2011 | Joint Bone Spine | pmid:21550285 |
Santini D et al. | Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. | 2011 | PLoS ONE | pmid:21559440 |
Mariúba MV et al. | Effect of triiodothyronine on the maxilla and masseter muscles of the rat stomatognathic system. | 2011 | Braz. J. Med. Biol. Res. | pmid:21584440 |